BRIEF: YSB Inc.’s profit triples in first half of 2025

9885.HK
Ribo does biotech

Pharmaceutical e-commerce platform YSB Inc. (9885.HK) announced on Thursday that it expects to record a net profit of 70 million yuan ($9.75 million) or more for the six months through June, more than triple the 21.8 million yuan it reported a year earlier.

The company credited the surge to steady revenue growth, strong demand for its high-margin self-branded products, and enhanced digital capabilities that improved the efficiency of its platform and direct-sales operations.

YSB‘s stock opened higher on Friday but later turn lower, closing at HK$10.02 by the midday break, down 2.34%. The stock is up 67.9% this year.

By Lee Shih Ta

To subscribe to Bamboo Works weekly free newsletter, click here

,
, ,

Related Articles

RELATED ARTICLES

  1. Kuaishou does entertainment
    BRIEF: ZX Inc. swings to profit in first half of 2025, rebrands as Tanwan
    9890.HK
  2. BRIEF: Keep Inc.’s loss narrows sharply in first half of 2025
    3650.HK
  3. BRIEF: China Ruyi returns to profit in first half of 2025
    0136.HK
  4. BRIEF: Kingboard records strong profit gain in first half of 2025
    0148.HK
  5. BRIEF: Shandong Gold profit surges in first half of 2025
    1787.HK
    600547.SHG
  6. BRIEF: Meitu reports strong profit growth in first half of 2025
    1357.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

Recent Articles

Geneplus IPO

Geneplus locks onto targeted medicine for IPO pitch

After a post-Covid earnings dip, the company is seeking a stable future as a provider of data and diagnostics for precision medicine and disease prevention   Key Takeaways: The company’s…

Hong Kong’s IPO rally under scrutiny, as ZTE hits new U.S. headwinds

Hong Kong's stock regulator has warned IPO underwriters over the declining qualiy of new listing applications. Is this a red flag for the city's booming IPO market, or just the usual regulatory caution? And the U.S. could fine telecoms equipment maker ZTE $1 billion for bribery in Brazil. Why does Washington think it can force ZTE to pay such a large amount?